NanoLogix Inc (NNLX)

[Emerald Isle]

The actual January 27, 2014 quote from a press release was:

"In a conservative estimate from a Saudi Arabian and GCC marketing expert based in Switzerland, the first year of sales for NanoLogix is projected to total $900,000 from this contract."
This is an estimate made by an outsider and published by Nanologix so it probably sounds reasonable based upon whatever demographic and business sector analysis used by that Saudi Arabian expert.

I could not find any further comment from Nanologix on the projected sales amount in any press release or company update, so the statement of "$900,000 in revenue which is the amount they plastered all over the net every opportunity they could get." is not correct. Please furnish your references on that to clear up the discrepancy for all of us. Posts from bulletin boards are not authoritative in this regard.

What is stated in April is that the company and the Nasaem Aljazira company are waiting for the Saudi Arabian FDA approval.

April 11, 2014:
Saudi Arabia FDA listing NanoLogix was informed today that Nasaem AlJazira has received notification their application for Saudi Arabian MDNR (Medical Device National Registration) listing for NanoLogix products has been approved. Saudi Arabia FDA approval is pending.

So, one would have to consider that sales in Saudi Arabia would not begin until after the Saudi Arabian FDA grants approval, and then we should begin to see revenue from that area.

I have not seen a further update on the status of that approval on the Nanologix website or in updates or press releases and so I will assume that it has not yet been granted. hopefully it will happen soon.